Clinical Trials Directory

Trials / Completed

CompletedNCT03350308

Prediction of Risk of Hypotension in Hemodialysis

Status
Completed
Phase
Study type
Observational
Enrollment
60 (actual)
Sponsor
University Hospital, Clermont-Ferrand · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The main objective is to establish a statistical predictive model of the risk of intradialytic hypotension during hemodialysis (HD) or hemodiafiltration (HDF) sessions based on the measurement of residual blood volume and excess extracellular hydration. The secondary objective is to study the impact of dysfunction in the mechanisms of compensation for decreased blood volume (heart disease, neuropathy, drugs) on the risk of intradialytic hypotension.

Detailed description

The duration of the study is 4 weeks for each patient. It will first be carried out a spectral analysis of heart rate variability (CHU of Clermont Ferrand only) and a measurement of intracellular and extracellular volumes by bioimpedancemetry. During the next 9 sessions, the decrease in the VSR will be recorded using an optical haematocrit measurement system. Blood pressure and heart rate will be measured every 30 minutes using an automatic blood pressure monitor and whenever the patient's nurse deems it necessary.

Conditions

Interventions

TypeNameDescription
OTHERhemodialysisThe main objective is to establish a statistical predictive model of the risk of intradialytic hypotension during hemodialysis (HD) or hemodiafiltration (HDF) sessions based on the measurement of residual blood volume and excess extracellular hydration

Timeline

Start date
2015-01-01
Primary completion
2023-12-27
Completion
2023-12-27
First posted
2017-11-22
Last updated
2024-12-12

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT03350308. Inclusion in this directory is not an endorsement.